Hong Kong's Prenetics agrees $1.25b SPAC merger
Hong Kong-based genetic testing business Prenetics has agreed to merge with a special purpose acquisition company (SPAC) sponsored by Adrian Cheng, scion of local property developer New World Development and managing partner of C Ventures, at an enterprise valuation of $1.25 billion.
Prenetics has raised $85 million in funding to date, including a $40 million round led by Alibaba Group’s Hong Kong Entrepreneur Fund and Beyond Ventures in 2017, and a $15 million round led by Apis...
More on Greater China
Latest News
Hitachi sells radiation devices business to Nippon Mirae Capital
Hitachi has agreed to sell its Japan-based radiation measurement devices and industrial x-ray CT devices businesses to local private equity firm Nippon Mirae Capital.
MBK agrees $1b China theme park deal
MBK Partners has agreed to buy five ocean theme parks in China – four operational and one under construction – from Hong Kong-listed Haichang Ocean Park Holdings for RMB6.53 billion ($1.01 billion).
China's Trustar buys European EV charging specialist
Trustar Capital, formerly known as CITIC Capital Partners, has invested an undisclosed sum in Intramco, a Europe-based manufacturer of components used in electric vehicle (EV) charging.
China's Vitalbridge closes Fund II at $275m
Vitalbridge Capital, a China-based venture capital firm that spun out from Trustbridge Partners, has raised $275 million for its second US dollar-denominated fund.